drugset / Trial / NCT00795171
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
RandomizedParallel-groupOpen-labelBasic science
Summary
Docetaxel and sunitinib will be compared to docetaxel for their effect on CEC/CEP spikes induced by docetaxel in HRPC patients
Timeline
- Start
- 2008-11
- Primary completion
- 2011-04
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | 37.5 mg | — |
| Background | Docetaxel | Small molecule | 75 mg/m2 | — |